Search clinical trials for: F18 FDG

Total 2400 results

University of Saskatchewan
Saskatoon Health Region; Sylvia Fedoruk Canadian Centre for Nuclear Innovation

Completed

Registry Type Study to Monitor for Adverse Drug Reactions to Fedoruk Manufactured [F-18]-Fludeoxyglucose

Positron-Emission Tomography and Cone-Beam Computed Tomography
Zhejiang University

Completed

18F-FAPI PET Imaging in Pancreatic Adenocarcinoma

Pancreas Adenocarcinoma | Diagnosis | Staging | 18F-FDG | 18F-FAPI

China
The Hospital for Sick Children

Completed

18FDG-PET Imaging to Detect Changes in Airways Inflammation in Cystic Fibrosis Patients

Cystic Fibrosis

Canada
National Institute of Neurological Disorders and...

Completed

Metabolic Abnormalities in Children With Epilepsy

Seizures | Generalized Epilepsy | Metabolic Disease | Infantile Spasms | Partial Epilepsy

United States
Mayo Clinic

Withdrawn

Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography (PEM-FES)

Breast Neoplasm

United States
University Health Network, Toronto

Recruiting

Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study

Head and Neck Squamous Cell Carcinoma

Canada
University Hospital, Caen

Unknown

Evaluation of the Diagnostic Value of PET (18F-FDG) in Chronic Graft Versus Host Disease (cGVH) (TEP-GVH)

Chronic Graft Versus Host Disease

France
Institut de cancérologie Strasbourg Europe

Recruiting

Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC) (ATICC)

Cervical Cancer

France
Centre Hospitalier Universitaire de Nīmes

Completed

Metabolic Anomolies Associated With the 6 Month Clinical Evolution of Patients Suffering From Motor Conversion Disorder (HYCORE)

Conversion Disorder

France
University Hospital, Strasbourg, France
Biogen

Terminated

Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri

Multiple Sclerosis

France
American College of Radiology Imaging Network
National Cancer Institute (NCI)

Terminated

FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy (ACRIN6678)

Lung Cancer

United States
Universitaire Ziekenhuizen KU Leuven

Completed

Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy

Esophageal Carcinoma (Squamous Cell Carcinoma - Adenocarcinoma)

Belgium
Washington University School of Medicine

Terminated

Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery

Rectal Neoplasms

United States
Virginia Commonwealth University
National Cancer Institute (NCI)

Withdrawn

Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer

Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung Cancer

United States
University of Pennsylvania

Withdrawn

The Use of PET/CT to Evaluate Synovitis in the Temporomandibular Joint (TMJ)

Temporomandibular Joint | Conservative Treatment Therapy

United States
National Cancer Institute (NCI)

Recruiting

18F-DCFPyL PET/CT in Hepatocellular Carcinoma

Hepatocellular Carcinoma

United States
IRCCS San Raffaele

Completed

Evaluation of Brain Functional Changes With 18F-FDG PET and Cognitive Processes After Brain Radiotherapy for Cavernous Sinus Meningiomas and Non-secreting ACTH Adenomas

Meningioma
Institut National de la Santé Et de la Recherche...

Completed

Brown Adipose Tissue in ALS (BATALS)

Amyotrophic Lateral Sclerosis

France
Assistance Publique - Hôpitaux de Paris

Completed

18-FDG PET/CT Imaging and Clinical Decisions in Infective Endocarditis (TEPvENDO)

Infective Endocarditis

France
Assiut University

Not yet recruiting

Validity of Mediastinal Blood Pool SUV Ratio

Validity of Blood Pool SUV Ratio in Identification of Malignancy in Case of Diseased Liver
University Health Network, Toronto

Active, not recruiting

Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors

Neuroendocrine Tumors

Canada
Wake Forest University Health Sciences
Lucerno Dynamics, LLC

Terminated

Infiltration Effect on SUV

Dose Response Relationship, Drug

United States
Duke University

Recruiting

Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx

Oropharynx Cancer

United States
Central Hospital, Nancy, France

Recruiting

Cognitive Disorders in Hereditary Spastic Paraplegia Type 4 (SPG-TEP)

Spastic Paraplegia

France
Siemens Molecular Imaging

Terminated

Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects

Breast Cancer

United States
Samsung Medical Center

Recruiting

Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer (IBFIC)

Carcinoma, Non-Small-Cell Lung | Immune Checkpoint Inhibitors

Korea, Republic of
Abramson Cancer Center of the University of Pennsylvania

Completed

Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)

Lymphoma

United States
Avid Radiopharmaceuticals

Completed

Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.

Frontotemporal Dementia | Alzheimer's Disease

United Kingdom
Guangxi Medical University

Unknown

MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma

Lymphoma

China
University College, London
Royal Free Hospital NHS Foundation Trust

Completed

Breast PET Feasibility (Breast PET)

Breast Neoplasm Female

United Kingdom
Rigshospitalet, Denmark

Enrolling by invitation

Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms

Neuroendocrine Tumors | Neuroendocrine Carcinoma | Neuroendocrine Carcinoma Metastatic | GEP-NET

Denmark
University Health Network, Toronto
Princess Margaret Hospital, Canada

Completed

MRI FDG PET Imaging Cervix

Cervical Cancer Squamous Cell

Canada
National Cancer Institute (NCI)

Completed

Imaging in MGUS, SMM and MM

Multiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma

United States
Assiut University

Unknown

F-18 FDG- PETCT in Staging and Recurrent Colorectal Cancer

Recurrence | Colo-rectal Cancer
Mayo Clinic

Completed

Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults

Alzheimer's Disease

United States
University Hospital, Angers

Completed

What's Happen Under the Calcification Process in Pseudoxanthoma Elasticum (GOCAPXE)

Pseudoxanthoma Elasticum

France
Kocaeli University

Completed

FDG (Fluorodeoxyglucose) Findings After COVID-19 Vaccination (fdg)

Vaccine Reaction | Oncology

Turkey
Yale University

Completed

Optimizing Acquisition Parameters and Interpretive Methods of FDG-PET/CT With Rb-82

Sarcoidosis

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Brown Adipose Tissue Activity and Age

Obesity | Ageing

Netherlands
American College of Radiology
National Cancer Institute (NCI); American College of Radiology Imaging Network

Terminated

Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer (ACRIN6682)

Cervical Cancer

United States
Hadassah Medical Organization

Unknown

Contribution of F-18 Fluoro-Deoxy-Glucose PET/CT (Positron Emission Tomography) to the Assessment of HCC (Hepato-cellular Carcinoma) Treatment Efficiency (HCC)

Hepatocellular Carcinoma

Israel
The European Uro-Oncology Group
Centre for Human Drug Research, Netherlands

Completed

PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide

Prostate Cancer Metastatic

Netherlands
University Hospital, Tours

Completed

FluoroAv45 Imaging Research-in Alzheimer's Disease (FAIR-AD)

Mild Cognitive Impairment | Alzheimer's Disease

France
Merck Sharp & Dohme LLC

Completed

Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer
National Cancer Institute (NCI)

Completed

F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast Cancer

United States
Mayo Clinic

Completed

PiB PET Scanning in Speech and Language Based Dementias

Primary Progressive Aphasia | Aphasia | Semantic Dementia | Apraxia of Speech | Primary Progressive Nonfluent Aphasia | PPA | Non-fluent Aphasia | Progressive Aphasia

United States
Ottawa Heart Institute Research Corporation
Bayer

Completed

Pilot Study to Evaluate Right Ventricular Function With Riociguat in CTEPH

Chronic Thromboembolic Pulmonary Hypertension

Canada
City of Hope Medical Center
National Cancer Institute (NCI)

Withdrawn

Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation

Stage IIIA Non-small Cell Lung Cancer
Abramson Cancer Center of the University of Pennsylvania

Completed

Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

United States
The First Affiliated Hospital of Xiamen University

Completed

Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer

Positron-Emission Tomography | Tumor, Solid

China

Search clinical trials for: F18 FDG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations